학술논문

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial
Document Type
Article
Author
Peyrin-Biroulet, LaurentHart, AilsaBossuyt, PeterLong, MillieAllez, MatthieuJuillerat, PascalArmuzzi, AlessandroLoftus, Edward VOstad-Saffari, ElhamScalori, AstridOh, Young STole, SwatiChai, AkikoPulley, JenniferLacey, StuartSandborn, William JAguilar, HumbertoAhmad, TariqAkriviadis, EvangelosAldeguer Mante, XavierAllez, MatthieuAltorjay, IstvanAnanthakrishnan, AshwinAndersen, VibekeAndreu Garcia, MontserratArmuzzi, AlessandroAumais, GuyAvni-Biron, IritAxler, JeffreyAyub, KamranBaert, FilipBafutto, MauroBamias, GeorgeBassan, IsaacBaum, CurtisBeaugerie, LaurentBehm, BrianBekal, PradeepBennett, MichaelBermejo San Jose, FernandoBernstein, CharlesBettenworth, DominikBhaskar, SudhirBiancone, LiviaBilir, BahriBlaeker, MichaelBloom, StuartBohman, VerleBosques Padilla, Francisco JavierBossuyt, PeterBouhnik, YoramBouma, GerdBourdages, RaymondBrand, StephanBressler, BrianBrückner, MarkusBuening, CarstenCarbonnel, FranckCaves, ThomasChapman, JonathonCheon, Jae HeeChiba, NaokiChioncel, CameliaChristodoulou, DimitriosClodi, MartinCohen, AlbertCorazza, Gino RobertoCorlin, RichardCosintino, RoccoCummings, FraserDalal, RobinDanese, SilvioDe Maeyer, MarcDe Magalhães Francesconi, Carlos FernandoDe Silva, AmindaDebinski, HenryDesreumaux, PierreDewit, OlivierD'Haens, GeertDi Felice Boratto, SandraDing, John NikDixon, TylerDryden, GeraldDu Vall, George AaronEbert, MatthiasEcharri Piudo, AnaEhehalt, RobertElkhashab, MagdyEnnis, CraigEtzel, JasonFallingborg, JanFeagan, BrianFejes, RolandFerraz de Campos Mazo, DanielFerreira de Almeida Borges, ValériaFischer, AndreasFixelle, AlanFleisher, MarkFowler, SharyleFreilich, BradleyFriedenberg, KeithFries, WalterFulop, CsabaFumery, MathurinFuster, SergioG Kiss, GyulaGarcia Lopez, SantiagoGassner, SonjaGill, KanwarGilletta de Saint Joseph, CyrielleGinsburg, PhilipGionchetti, PaoloGoldin, EranGoldis, Adrian-EugenGomez Jaramillo, Hector AlejandroGonciarz, MaciejGordon, GlennGreen, DanielGrimaud, Jean-CharlesGuajardo Rodriguez, RogelioGurzo, ZoltanGutierrez, AlexandraGyökeres, TiborHahm, Ki BaikHanauer, StephenHanson, JohnHarlan III, WilliamHasselblatt, PeterHayee, BuhussainHebuterne, XavierHendy, PeterHeyman, MelvinHiggins, PeterHilal, RaoufHindryckx, PieterHoentjen, FrankHoffmann, PeterHoltkamp-Endemann, FrankHoltmann, GeraldHorvat, GyulaHowaldt, StefanieHuber, SamuelIbegbu, IkechukwuIborra Colomino, Maria IsabelIrving, PeterIsaacs, KimJagarlamudi, KiranJain, RajeshJankiel Miszputen, SenderJansen, JeroenJones, JenniferJuillerat, PascalKaragiannis, JohnKaryotakis, NicholasKaser, ArthurKatz, LiorKatz, SeymourKatz, LeoKaur, NirmalKazenaite, EditaKhanna, ReenaKhurana, SunilKim, Joo SungKim, Young-HoKim, Sung KookKim, DongwooKlaus, JochenKleczkowski, DariuszKohout, PavelKorczowski, BartoszKouklakis, GeorgiosKoutroubakis, IoannisKrause, RichardKristof, TundeKronborg, IanKrummenerl, AnnetteKupcinskas, LimasLaborda Molteni, JorgeLaharie, DavidLahat-zok, AdiLee, JonghunLee, Kang-MoonLeong, RupertLevine, HenryLimdi, JimmyLindsay, JamesLodhia, NileshLoftus, EdwardLongman, RandyLopez Serrano, PilarLouis, EdouardLouzada Pereira, Maria HelenaLowe, JohnLueth, StefanLukas, MilanMaconi, GiovanniMacrae, FinlayMadi-Szabo, LaszloMahadevan-Velayos, UmaMalluta, Everson FernandoMana, FaziaMannon, PeterMantzaris, GerasimosMarin Jimenez, IgnacioMartin Arranz, Maria DoloresMateescu, Radu-BogdanMazzoleni, FelipeMeder, AgnieszkaMelzer, EhudMertens, JessicaMimidis, KonstantinosMitchell, BrentMolnar, TamasMoore, GregoryMorales Garza, Luis AlonsoMountifield, RemeMuls, VincianeMurray, CharlesNagy, BelaNeurath, MarkusNguyen, AugustinPanaccione, RemoPandak, WilliamPanes Diaz, JulianPark, JihyePastorelli, LucaPatel, BhaktasharanPeck-Radosavljevic, MarkusPecsi, GyulaPeerani, FarhadPerez Gisbert, JavierPesta, MartinPetryka, RobertPeyrin-Biroulet, LaurentPhillips, RaymondPierik, MariekePratha, VijayalakshmiProchazka, VlastimilRacz, IstvanRadford-Smith, GrahamRamos Castañeda, DanielRamos Júnior, OderyRegula, JaroslawReimund, Jean-MarieRobbins, BryanRoblin, XavierRogai, FrancescaRogler, GerhardRozciecha, JerzyRubin, DavidRuiz Flores, Azalia YuririaRupinski, MaciejRydzewska, GrazynaSaha, SumonaSaibeni, SimoneSalamon, AgnesSallo, ZoltanSalzberg, BruceSamuel, DouglasSamuel, SunilSandborn, WilliamSavarino, Edoardo VincenzoSchirbel, AnjaSchnabel, RobertSchreiber, StefanScott, JohnSedghi, ShahriarSeibold, FrankSeidelin, JakobSeidler, UrsulaShaban, AhmadShafran, IraSheikh, AasimSherman, AlexShirin, HaimSmolinski, PatrykSong, Geun AmSoufleris, KonstantinosSpeight, AlexanderStaessen, DirkStallmach, AndreasStaun, MichaelStein, DanielSteinhart, HillaryStifft, JonathasStokesberry, DavidSturm, AndreasSultan, KeithSzekely, GyorgyTagore, KuldeepTanno, HugoThin, LenaThiwan, SyedThomas, CarltonTichy, MichalToth, Gabor TamasTulassay, ZsoltUlbrych, JanValentine, JohnVarga, MartaVasconcellos, EduardoVaughn, ByronVelasco, BrendaVelazquez, FranciscoVermeire, SeverineVilla, EricaVincze, AronVogelsang, HaraldVolfova, MiroslavaVuitton, LucineVyhnalek, PetrWahab, PeterWalldorf, JensWaterman, MattitiahuWeber, JohnWeiss, L. MichaelWiechowska-Kozlowska, AnnaWiesner, EliseWitthoeft, ThomasWohlman, RobertWozniak-Stolarska, BarbaraYacyshyn, BruceYe, Byong-DukYounes, ZiadYukie Sassaki, LígiaZaltman, CyrlaZeuzem, Stefan
Source
The Lancet Gastroenterology & Hepatology; February 2022, Vol. 7 Issue: 2 p128-140, 13p
Subject
Language
ISSN
24681253
Abstract
Etrolizumab is a gut-targeted, anti-β7 integrin, monoclonal antibody. In an earlier phase 2 induction study, etrolizumab significantly improved clinical remission compared with placebo in patients with moderately to severely active ulcerative colitis. We aimed to evaluate the efficacy and safety of etrolizumab in patients with moderately to severely active ulcerative colitis who had been previously treated with anti-tumour necrosis factor (TNF) agents.